|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:9–90. 2011. View Article : Google Scholar
|
|
2
|
Sarela AI, Turnbull AD, Coit DG, et al:
Accurate lymph node staging is of greater prognostic importance
than subclassification of the T2 category for gastric
adenocarcinoma. Ann Surg Oncol. 10:783–791. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kunisaki C, Shimada H, Nomura M, et al:
Distribution of lymph node metastasis in gastric carcinoma.
Hepatogastroenterology. 53:468–472. 2006.PubMed/NCBI
|
|
4
|
Potrc S, Gadiijev E, Hajdinjak T, et al:
Clinicopathological and immunohistochemical markers after radical
gastrectomy for gastric cancer. Hepatogastroenterology. 54:308–314.
2007.PubMed/NCBI
|
|
5
|
Greene FL, Page DL, Fleming ID, et al:
AJCC Cancer Staging Manual. 6th edition. Springer-Verlag; New York:
2002, View Article : Google Scholar
|
|
6
|
Ebert MP, Fei G, Kahmann S, et al:
Increased beta-catenin mRNA levels and mutational alterations of
the APC and beta-catenin gene are present in intestinal-type
gastric cancer. Carcinogenesis. 23:87–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El-Rifai W and Powell SM: Molecular
biology of gastric cancer. Semin Radiat Oncol. 12:128–140. 2002.
View Article : Google Scholar
|
|
8
|
Cmarik JL, Min H, Hegamyer G, et al:
Differentially expressed protein Pdcd4 inhibits tumor
promoter-induced neoplastic transformation. Proc Natl Acad Sci USA.
96:14037–14042. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Soejima H, Miyoshi O, Yoshinaga H, et al:
Assignment of the programmed cell death 4 gene (PDCD4) to human
chromosome band 10q24 by in situ hybridization. Cytogenet Cell
Genet. 87:113–114. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Afonja O, Juste D, Das S, et al: Induction
of PDCD4 tumour suppressor gene expression by RAR agonists,
antiestrogen and HER-2/neu antagonist in breast cancer cells.
Evidence for a role in apoptosis. Oncogene. 23:8135–8145. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bitomsky N, Wethkamp N, Marikkannu R, et
al: siRNA-mediated knockdown of PDCD4 expression causes
upregulation of p21 (Waf1/Cip1) expression. Oncogene. 27:4820–4829.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carayol N, Katsoulidis E, Sassano A, et
al: Suppression of programmed cell death 4 (PDCD4) protein
expression by BCR-ABL-regulated engagement of the mTOR/p70 S6
kinase pathway. J Biol Chem. 283:8601–8610. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshinaga H, Matsuhashi S, Fujiyama C, et
al: Novel human PDCD4 (H731) gene expressed in proliferative cells
is expressed in the small duct epithelial cells of the breast as
revealed by an anti-H731 antibody. Pathol Int. 49:1067–1077. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Knosel T, Kristiansen G, et al:
Loss of PDCD4 expression in human lung cancer correlates with
tumour progression and prognosis. J Pathol. 200:640–646. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mudduluru G, Medved F, Grobholz R, et al:
Loss of programmed cell death 4 expression marks adenoma-carcinoma
transition, correlates inversely with phosphorylated protein kinase
B, and is an independent prognostic factor in resected colorectal
cancer. Cancer. 110:1697–1707. 2007. View Article : Google Scholar
|
|
16
|
Zhang H, Ozaki I, Mizuta T, et al:
Involvement of programmed cell death 4 in transforming growth
factor-beta1-induced apoptosis in human hepatocellular carcinoma.
Oncogene. 25:6101–6112. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Motoyama K, Inoue H, Mimori K, et al:
Clinicopathological and prognostic significance of PDCD4 and
microRNA-21 in human gastric cancer. Int J Oncol. 36:1089–1095.
2010.PubMed/NCBI
|
|
18
|
Asangani IA, Rasheed SA, Nikolova DA, et
al: MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor
suppressor Pdcd4 and stimulates invasion, intravasation and
metastasis in colorectal cancer. Oncogene. 27:2128–2136. 2008.
View Article : Google Scholar
|
|
19
|
Wang X, Wei Z, Gao F, et al: Expression
and prognostic significance of PDCD4 in human epithelial ovarian
carcinoma. Anticancer Res. 28:2991–2996. 2008.PubMed/NCBI
|
|
20
|
Gao F, Wang X, Zhu F, et al: PDCD4 gene
silencing in gliomas is associated with 5′CpG island methylation
and unfavourable prognosis. J Cell Mol Med. 13:4257–4267. 2009.
|
|
21
|
Shibahara K, Asano M, Ishida Y, et al:
Isolation of a novel mouse gene MA-3 that is induced upon
programmed cell death. Gene. 166:297–301. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Z and DuBois RN: Detection of
differentially expressed genes in human colon carcinoma cells
treated with a selective COX-2 inhibitor. Oncogene. 20:4450–4456.
2001. View Article : Google Scholar : PubMed/NCBI
|
